Article
Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey method.
BMC genomics - 20 Apr 2021
Yoshino Yuta, Kumon Hiroshi, Mori Takaaki, Yoshida Taku, Tachibana Ayumi, Shimizu Hideaki, Iga Jun-Ichi, Ueno Shu-Ichi
Abstract excerpt
BACKGROUND: Alanine:glyoxylate aminotransferase 2 (AGXT2; EC 2.6.1.44) is the only enzyme that degrades the R-form of 3-aminoisobutyrate, an intermediate metabolite of thymine. AGXT2, as well as diaminoarginine dimethylaminohydrolase 1 (DDAH1; EC 3.5.3.18), works as an enzyme that degrades asymmetric dimethylarginine (ADMA), which competitively inhibits the nitric oxide synthase family. Thus, these two enzyme...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
